About this episode
As a number of existing therapies are being re-purposed to help patients with the most severe Covid-19 symptoms, we speak to a UK-based bioscience company about a drug they've developed and explore how it is being used in Italy. Guests: Tom Whipple, The Times science editor Someit Sidhu, CEO and Co-founder of Izana Bioscience Host: Manveen Rana This podcast was brought to you thanks to subscribers of The Times and The Sunday Times. To enjoy unlimited digital access to all our journalism subscribe here . Hosted on Acast. See acast.com/privacy for more information.